Cargando…
SEC23B Loss-of-Function Suppresses Hepcidin Expression by Impairing Glycosylation Pathway in Human Hepatic Cells
Biallelic pathogenic variants in the SEC23B gene cause congenital dyserythropoietic anemia type II (CDA II), a rare hereditary disorder hallmarked by ineffective erythropoiesis, hemolysis, erythroblast morphological abnormalities, and hypo-glycosylation of some red blood cell membrane proteins. Abno...
Autores principales: | Rosato, Barbara Eleni, Marra, Roberta, D’Onofrio, Vanessa, Del Giudice, Federica, Della Monica, Simone, Iolascon, Achille, Andolfo, Immacolata, Russo, Roberta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835815/ https://www.ncbi.nlm.nih.gov/pubmed/35163229 http://dx.doi.org/10.3390/ijms23031304 |
Ejemplares similares
-
Genetics and Genomics Approaches for Diagnosis and Research Into Hereditary Anemias
por: Russo, Roberta, et al.
Publicado: (2020) -
P1470: IDENTIFICATION OF THE PRO20THR NOVEL VARIANT IN CDIN1 GENE ALLOWED EXPLORING THE BIOLOGICAL PROCESSES IMPAIRED IN CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE I
por: Marra, Roberta, et al.
Publicado: (2023) -
P1468: PIEZO1 GAIN-OF-FUNCTION VARIANTS ACCOUNT FOR STRESSED ERYTHROPOIESIS BY ALTERING APOPTOSIS, HYPOXIA CELL RESPONSE, AND GLYCOLYSIS
por: Eleni Rosato, Barbara, et al.
Publicado: (2023) -
RAP-011 Rescues the Disease Phenotype in a Cellular Model of Congenital Dyserythropoietic Anemia Type II by Inhibiting the SMAD2-3 Pathway
por: De Rosa, Gianluca, et al.
Publicado: (2020) -
Clinical exome-based panel testing for medically actionable secondary findings in a cohort of 383 Italian participants
por: Martone, Stefania, et al.
Publicado: (2022)